Sunesis Pharmaceuticals Inc. (SNSS)

2.51
0.00 (0.00)
NASDAQ : Health Technology
Prev Close 2.51
Open 2.60
Day Low/High 2.50 / 2.60
52 Wk Low/High 1.82 / 7.69
Volume 23.36K
Avg Volume 282.40K
Exchange NASDAQ
Shares Outstanding 34.35M
Market Cap 93.43M
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Sunesis Pharmaceuticals Reaches Analyst Target Price

Sunesis Pharmaceuticals Reaches Analyst Target Price

In recent trading, shares of Sunesis Pharmaceuticals Inc have crossed above the average analyst 12-month target price of $6.00, changing hands for $6.02/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Sunesis Pharmaceuticals Reports Third Quarter 2017 Financial Results And Recent Highlights

Sunesis Pharmaceuticals Reports Third Quarter 2017 Financial Results And Recent Highlights

Sunesis to Host Conference Call Today at 2:00 PM Eastern Time

Sunesis Pharmaceuticals Reports Second Quarter 2017 Financial Results And Recent Highlights

Sunesis Pharmaceuticals Reports Second Quarter 2017 Financial Results And Recent Highlights

Sunesis to Host Conference Call Today at 2:00 PM Eastern Time

Sunesis Pharmaceuticals Reports First Quarter 2017 Financial Results And Recent Highlights

Sunesis to Host Conference Call Today at 2:00 PM Eastern Time

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Sunesis Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Sunesis Pharmaceuticals, Inc.

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of Sunesis Pharmaceuticals, Inc. And Advises Investors With Losses To Contact The Firm

Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Sunesis Pharmaceuticals, Inc.